Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
475085-57-5
Purity
95%
MRE-269 is an active metabolite of selexipag. It is a selective agonist for the human IP receptor with a Ki =12 nM.
Properties
Name
MRE-269
Smiles
CC(C)N(CCCCOCC(=O)O)C=1C=NC(C=2C=CC=CC2)=C(N1)C=3C=CC=CC3
Targets
Please log in to see this information
SDS
ACT-333679 | MRE-269
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$110
2 mg
$112
5 mg
$120
10 mg
$133
15 mg
$186
20 mg
$238
25 mg
$304
30 mg
$347
35 mg
$383
40 mg
$428
45 mg
$472
50 mg
$524
75 mg
$678
100 mg
$750
Quantity
1
Total amount
$ 120
ACT-333679 | MRE-269
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.